Page 1 of Clinical Trials for Biological allogeneic tumor cell vaccine, 57 Total Matches
- 1RecruitingLast Updated: April 10, 2012Condition(s): Lung Cancer; Esophageal Cancer; Malignant Pleural Mesothelioma; Thymoma; Thymic Carcinoma
- 2RecruitingLast Updated: March 14, 2012Condition(s): Sarcoma; Melanoma; Epithelial Malignancies; Pleural Malignancies
- 3WithdrawnLast Updated: April 27, 2011Condition(s): Chronic Myeloid Leukemia
- 4SuspendedLast Updated: February 18, 2011Condition(s): Prostate Cancer
- 5CompletedLast Updated: June 11, 2009Condition(s): Breast Cancer; Colorectal Cancer; Kidney Cancer; Lung Cancer; Malignant Mesothelioma; Pancreatic Cancer
- 6RecruitingLast Updated: July 7, 2009Condition(s): Colorectal Cancer; Metastatic Cancer
- 7WithdrawnLast Updated: April 7, 2011Condition(s): Metastatic Solid Tumors
- 8CompletedLast Updated: February 6, 2009Condition(s): Pancreatic Cancer
- 9CompletedLast Updated: July 28, 2010Condition(s): Lung Neoplasm; Carcinoma, Bronchogenic
- 10CompletedLast Updated: February 6, 2009Condition(s): Prostate Cancer
- 11RecruitingLast Updated: April 11, 2012Condition(s): Neuroblastoma
- 12CompletedLast Updated: April 26, 2010Condition(s): Lung Cancer
- 13Active, not recruitingLast Updated: January 27, 2012Condition(s): Pancreatic Cancer
- 14Active, not recruitingLast Updated: July 19, 2011Condition(s): Anorexia; Fatigue; Pain; Pancreatic Cancer; Psychosocial Effects of Cancer and Its Treatment
- 15Active, not recruitingVaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung CancerLast Updated: August 19, 2011Condition(s): Lung Cancer
- 16Not yet recruitingLast Updated: May 9, 2012Condition(s): Pancreatic Cancer
- 17TerminatedLast Updated: June 30, 2009Condition(s): Breast Cancer
- 18CompletedLast Updated: June 30, 2009Condition(s): Malignant Melanoma
- 19CompletedLast Updated: June 30, 2009Condition(s): Prostate Cancer
- 20Active, not recruitingLast Updated: February 20, 2012Condition(s): Lung Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+allogeneic+tumor+cell+vaccine
